NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AcuSense BioMedical Technology Corp.

AcuSense BioMedical Technology Corp.

Private
TaiwanHealthcare & Life Scienceshttps://acusense.com.tw/

Last Round

Private Placement

Jan 8, 2024

Total Funding Raised

$10,000

Company Overview

AcuSense BioMedical Technology Corp. is a healthtech company that develops medical monitoring devices and solutions using artificial intelligence and the Internet of Things to improve patient safety and clinical efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sensors, NLP & Conversational AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

blood leakage detectionhemodialysis monitoringAIoMTpatient safetymedical IoTremote patient monitoringsoftware as a medical deviceSaMDmedical devicesAI early warning systemhypotension predictionhealthcare chatbotsmart wardsmart tourniquetmedical device OEMISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AcuSense BioMedical Technology Corp. Comps

Public and private peers based on sector, stage, and business model.

AcuSense BioMedical Technology Corp. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AcuSense BioMedical Technology Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJan 8, 2024
AcceleratorMar 1, 2023
AcceleratorJul 1, 2021
GrantMay 6, 2021
AcceleratorJan 1, 2021
Accelerator
Feb 1, 2020

Key People

Founding team and executive leadership

Kuanyu Chen

CEO

Executive Team

Kenji Hsueh

Chief Technology Officer

Executive Team

AcuSense BioMedical Technology Corp. Investors

Notable investors and investment history

AcuSense BioMedical Technology Corp. investors
InvestorRounds
StarFab AcceleratorAccelerator
Taiwan Accelerator PlusAccelerator
CaelestinusAccelerator
BE AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 51% MoM.

  • Jun 6, 2025

    Grew 75% QoQ from 4 to 7 employees.

AcuSense BioMedical Technology Corp. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AcuSense BioMedical Technology Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AcuSense BioMedical Technology Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaiwan
Employee Range4
Year Founded2017
Last FundingJan 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.